{"id":"https://openalex.org/W2894563559","doi":"https://doi.org/10.1093/ofid/ofy210.1205","title":"1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic","display_name":"1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2894563559","doi":"https://doi.org/10.1093/ofid/ofy210.1205","mag":"2894563559"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofy210.1205","doi":"https://doi.org/10.1093/ofid/ofy210.1205","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1205","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofy210.1205","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025379878","display_name":"Steven M. Opal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Opal","raw_affiliation_strings":["Warren Alpert Medical School, Brown University, Providence, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Warren Alpert Medical School, Brown University, Providence, Rhode Island","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113451778","display_name":"Thomas M. File","orcid":"https://orcid.org/0009-0009-6080-467X","observed_orcids":["https://orcid.org/0009-0009-6080-467X"]},"institutions":[{"id":"https://openalex.org/I1294639003","display_name":"Summa Health System","ror":"https://ror.org/03p6fpw74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294639003"]},{"id":"https://openalex.org/I95240055","display_name":"Northeast Ohio Medical University","ror":"https://ror.org/04q9qf557","country_code":"US","type":"education","lineage":["https://openalex.org/I95240055"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas M File","raw_affiliation_strings":["Northeast Ohio Medical University, Rootstown, Ohio","Summa Health, Akron, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northeast Ohio Medical University, Rootstown, Ohio","institution_ids":["https://openalex.org/I95240055"]},{"raw_affiliation_string":"Summa Health, Akron, Ohio","institution_ids":["https://openalex.org/I1294639003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048965254","display_name":"Tom van der Poll","orcid":"https://orcid.org/0000-0002-9199-5079","observed_orcids":["https://orcid.org/0000-0002-9199-5079"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tom Van Der Poll","raw_affiliation_strings":["Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands","Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053622214","display_name":"Paul C. McGovern","orcid":"https://orcid.org/0000-0002-5906-2818","observed_orcids":["https://orcid.org/0000-0002-5906-2818"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul McGovern","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043695605","display_name":"Evan L. Tzanis","orcid":"https://orcid.org/0000-0002-4103-750X","observed_orcids":["https://orcid.org/0000-0002-4103-750X"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Tzanis","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062874736","display_name":"Surya Chitra","orcid":"https://orcid.org/0000-0002-5682-9200","observed_orcids":["https://orcid.org/0000-0002-5682-9200"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surya Chitra","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania","institution_ids":["https://openalex.org/I4210101063"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"suppl_1","first_page":"S421","last_page":"S421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.6401000022888184,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.6401000022888184,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.24230000376701355,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.049300000071525574,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omadacycline","display_name":"omadacycline","score":0.953000009059906},{"id":"https://openalex.org/keywords/aminomethylcycline","display_name":"aminomethylcycline","score":0.9660000205039978},{"id":"https://openalex.org/keywords/antibiotic-safety","display_name":"antibiotic safety","score":0.7919999957084656},{"id":"https://openalex.org/keywords/acute-bacterial-skin-and-skin-structure-infections","display_name":"acute bacterial skin and skin structure infections","score":0.9570000171661377},{"id":"https://openalex.org/keywords/community-acquired-bacterial-pneumonia","display_name":"community-acquired bacterial pneumonia","score":1.0},{"id":"https://openalex.org/keywords/linezolid","display_name":"linezolid","score":0.8180000185966492},{"id":"https://openalex.org/keywords/moxifloxacin","display_name":"moxifloxacin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8519999980926514},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7829999923706055},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.5730000138282776},{"id":"https://openalex.org/keywords/electrocardiographic-findings","display_name":"electrocardiographic findings","score":0.5080000162124634},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4580000042915344},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.878206193447113},{"id":"https://openalex.org/C2781414143","wikidata":"https://www.wikidata.org/wiki/Q411377","display_name":"Linezolid","level":5,"score":0.7171366810798645},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6339497566223145},{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.6063680052757263},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5268411040306091},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4627390503883362},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.44312572479248047},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.44137272238731384},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3821207284927368},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.17792826890945435},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.17673277854919434},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.13002216815948486},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09083202481269836},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofy210.1205","doi":"https://doi.org/10.1093/ofid/ofy210.1205","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1205","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5222889","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6252771","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6252771","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6252771","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofy210.1205","doi":"https://doi.org/10.1093/ofid/ofy210.1205","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.1205","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4407455153","https://openalex.org/W2965182241","https://openalex.org/W7162283100","https://openalex.org/W4389029164","https://openalex.org/W3119556869","https://openalex.org/W2905468129","https://openalex.org/W4224297011","https://openalex.org/W3001005446","https://openalex.org/W2745806880","https://openalex.org/W2768638529"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Omadacycline":[2],"(OMC)":[3],"is":[4,19,60],"a":[5,336],"novel":[6],"aminomethylcycline":[7],"with":[8,185,235,342,353,357],"activity":[9],"against":[10],"Gram-positive,":[11],"many":[12],"Gram-negative,":[13],"anaerobic,":[14],"and":[15,27,35,40,118,155,163,168,180,209,231,250,268,275,286,292,306,355,391,395],"atypical":[16],"pathogens.":[17],"It":[18],"in":[20,73,79,90,102,166,175,226,241,254,314,329,351],"clinical":[21,51],"development":[22],"as":[23,324],"once-daily":[24],"oral":[25],"(PO)":[26],"intravenous":[28],"(IV)":[29],"monotherapy":[30],"for":[31,149,273,283],"acute":[32],"bacterial":[33,42],"skin":[34,36],"structure":[37],"infections":[38,326],"(ABSSSI)":[39],"community-acquired":[41],"pneumonia":[43],"(CABP).":[44],"Cumulative":[45],"safety":[46,58,339],"results":[47],"from":[48],"Phase":[49],"3":[50],"trials":[52],"are":[53],"reported.":[54],"Methods":[55],"This":[56],"pooled":[57],"analysis":[59],"based":[61],"on":[62],"2,150":[63],"subjects:":[64],"OASIS-1":[65],"(N":[66,70,76],"=":[67,71,77,93,105,138,142],"645),":[68],"OASIS-2":[69],"735)":[72],"ABSSSI;":[74],"OPTIC":[75],"770)":[78],"CABP.":[80],"Comparators":[81],"were":[82,153,161,173,194,217,246,327],"linezolid":[83],"(LZD)":[84],"600":[85],"mg":[86,98],"IV":[87,99,133],"then":[88,100,134],"PO":[89,101,135,147],"ABSSSI":[91,167,354],"(n":[92,104],"689);":[94],"moxifloxacin":[95],"(MOX)":[96,182],"400":[97],"CABP":[103,169],"388).":[106],"Safety":[107],"parameters":[108],"included":[109],"treatment-emergent":[110],"adverse":[111,321],"events":[112,187,322],"(TEAEs),":[113],"laboratory":[114],"evaluations,":[115],"vital":[116],"signs,":[117],"electrocardiogram":[119],"(ECG)":[120],"findings.":[121],"Results":[122],"A":[123],"total":[124],"of":[125,183,238,278,302],"1,073":[126],"subjects":[127,271,295,352],"received":[128,131,145],"OMC:":[129],"705":[130],"OMC":[132,146,338,346],"(ABSSSI,":[136],"n":[137,141],"323;":[139],"CABP,":[140,356],"382);":[143],"368":[144],"only":[148],"ABSSSI.":[150],"Overall,":[151],"60.6%":[152],"male":[154],"91.6%":[156],"white;":[157],"mean":[158],"age":[159],"ranges":[160],"44.7\u201345.1":[162],"60.9\u201362.1":[164],"years":[165],"studies,":[170],"respectively.":[171],"TEAEs":[172,193,245,280],"observed":[174,225],"47.5%":[176],"(OMC),":[177],"41.2%":[178],"(LZD),":[179],"48.5%":[181],"subjects,":[184,234],"gastrointestinal":[186],"the":[188,218],"most":[189,219],"common":[190],"TEAEs.":[191,222],"Serious":[192],"low":[195],"(3.6%":[196],"OMC,":[197,204,212,228,259,265,284,289],"1.9%":[198],"LZD,":[199,206,214,230,261,267,285,291],"6.7%":[200],"MOX).":[201],"Nausea":[202],"(14.9%":[203],"8.7%":[205],"5.4%":[207],"MOX)":[208,216],"vomiting":[210],"(8.3%":[211],"3.9%":[213],"1.5%":[215,260],"frequently":[220],"reported":[221],"Diarrhea":[223],"was":[224,281,347],"2.4%":[227],"2.9%":[229],"8.0%":[232],"MOX":[233,270,294],"no":[236],"cases":[237],"Clostridium":[239],"difficile":[240],"OMC-treated":[242],"subjects.":[243],"Most":[244],"mild":[247],"to":[248],"moderate":[249],"did":[251],"not":[252],"result":[253],"study":[255],"drug":[256],"discontinuation":[257],"(3.1%":[258],"7.0%":[262],"MOX);":[263],"4":[264],"1":[266],"0":[269],"discontinued":[272],"nausea":[274],"vomiting.":[276],"Frequency":[277],"hepatic":[279],"similar":[282,328],"MOX:":[287],"4.3%":[288],"4.1%":[290],"4.5%":[293],"had":[296,308],"post-baseline":[297,313],"ALT":[298],">3\u00d7":[299],"upper":[300],"limit":[301],"normal.":[303],"Vital":[304],"signs":[305],"ECGs":[307],"comparable":[309],"clinically":[310],"notable":[311],"values":[312],"each":[315],"treatment":[316,359],"group.":[317],"Known":[318],"tetracycline":[319,344],"class":[320],"such":[323],"fungal":[325],"all":[330],"groups.":[331],"Conclusion":[332],"Pooled":[333],"analyses":[334],"demonstrate":[335],"favorable":[337],"profile,":[340],"consistent":[341],"its":[343],"heritage.":[345],"generally":[348],"well":[349],"tolerated":[350],"infrequent":[358],"discontinuations.":[360],"Disclosures":[361],"T.":[362,407],"M.":[363],"File":[364],"Jr.,":[365],"BioMerieux:":[366],"Consultant,":[367,371,376,380,385,400,404,413],"Consulting":[368,372,377,381,386,393,401,405,414],"fee;":[369,373,378,382,387,402],"Curetis:":[370],"Melinta":[374],"Therapeutics:":[375,389],"Merck:":[379],"Motif":[383],"Bio:":[384],"Nabriva":[388],"Consultant":[390],"Investigator,":[392],"fee":[394],"Research":[396],"grant;":[397],"Paratek":[398,411,418,424],"Pharmaceuticals:":[399,412,419,425],"Pfizer:":[403],"fee.":[406,415],"Van":[408],"Der":[409],"Poll,":[410],"P.":[416],"McGovern,":[417],"Employee,":[420,426],"Salary.":[421,427],"E.":[422],"Tzanis,":[423]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-10-12T00:00:00"}